Two reports describe new observational research suggesting that GLP-1 medications may be associated with a lower risk of developing breast cancer. The studies analyze health data for more than 110,000 women, with participants typically aged in the mid-40s to around 80. Researchers compare outcomes between women who use GLP-1 drugs and those who do not. Across sources, the reported reduction in breast cancer incidence is on the order of about 30%, with one report stating the decrease may be as high as 35% and another describing roughly a 30% reduction. The findings relate specifically to the development of breast cancer rather than cancer outcomes after diagnosis. Both articles present the result as a potential beneficial effect that may extend beyond a single cancer type, while the evidence base is framed as coming from a large-scale study rather than a randomized clinical trial. The reports do not provide definitive proof of causation, and they focus on the risk association observed in the cohort.
Study finds GLP-1 drugs linked to lower breast cancer risk in large cohort
Two reports describe new observational research suggesting that GLP-1 medications may be associated with a lower risk of developing breast cancer. The studies analyze health data for more than 110,000...
- A new study includes data for about 110,000 women (more than 111,000 in one report).
- Women taking GLP-1 medications show a lower risk of developing breast cancer compared with those not taking them.
- The reported risk reduction is about 30%, with one source citing up to 35%.
- The findings are based on a large observational cohort analysis, not a randomized trial.
- The research is presented as suggesting potential benefits across cancer types, though the reported association focuses on breast cancer incidence.
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.
2 months agoA study of 110,000 women, showing those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not
2 months ago
FAA seeks to discipline LaGuardia controllers after March fatal Air Canada collision
Two air traffic controllers at New York’s LaGuardia Airport are facing potential dismissal after the FAA determines they...
Lindsay Clancy jurors resume deliberations after second day ends without verdict
Jurors in the murder trial of Lindsay Clancy are scheduled to resume deliberations after a second day of discussion ends...
Two men accused of posing as 49ers player in $1.3 million romance scam
Federal prosecutors and the FBI say two men run a multistate scheme in which one allegedly posed as a San Francisco 49er...